GVHD Prophylaxis With Post-transplantation Bendamustine in Refractory Leukemia

Clinical trial NCT02799147 · COMPLETED

Trial details

NCT number: NCT02799147
Sponsor: St. Petersburg State Pavlov Medical University
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Leukemia, Acute Lymphoblastic Acute Myeloid Leukemia Mixed-Lineage Acute Leukemias

Start date: 2016-06-01
Primary completion: 2020-11-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.